Bitcoin Holds Steady at $61K Amid Recent Market Turbulenceby John Darbie 25.06.2024Bitcoin stabilizes at $61K after a dip to $59.2K, driven by ETF outflows, Mt. Gox redemptions, and miner sales, while ...
Cryptocurrency Price Update: Bitcoin Dips, Solana Gainsby John Darbie 25.06.2024Crypto Market Update: Bitcoin dips below $62k as downtrend continues; ETH, DOGE, and SOL show mixed performances; Fetch.ai leads gains, ...
Power Finance Corp Shares Drop; Price Target at ₹520by Mark Eisenberg 25.06.2024Power Finance Corp share price drops to ₹484.05, signaling short-term bearish trends despite strong buy ratings and a target of ...
Bitcoin Price Forecast: Indicators Signal Potential 100% Rallyby John Darbie 25.06.2024Experts say Bitcoin could soon rally by 100%. Key indicators like the Crosby Ratio and RSI suggest now might be ...
Bitcoin’s Supply in Profit Drops Amid Post-Halving Effectsby John Darbie 25.06.2024Bitcoin’s supply in profit drops to 80% post-halving, reflecting market changes. Key historical data and recent trends offer vital investment ...
David Kain on CDK Global: Cyberattack Lessons for Dealershipsby Lilu Anderson 25.06.2024David Kain on CDK Cyberattack: Learn from the recent attack's key insights on fortified cybersecurity and robust contingency planning for ...
Nvidia’s CFO Jankowski Leaves for Startup, Cites Tough Decisionby Mark Eisenberg 25.06.2024Nvidia's VP of Finance, Simona Jankowski, departs for a startup role, marking a notable shift amid Nvidia's monumental growth and ...
Sonendo Exec Sells Stock; Details on 2024 Revenue Guidanceby Mark Eisenberg 25.06.2024Sonendo’s Chief Talent Officer Roy T. Chen sells $700+ in stocks to cover tax obligations on RSU vesting, maintaining significant ...
Binance CEO: Bitcoin to Surpass $80K by 2025; Solana & BNB to Riseby John Darbie 25.06.2024Binance CEO predicts Bitcoin will hit $80K by 2025, sparking interest in altcoins like Solana, Rollblock, and Binance Coin as ...
CTT Pharma CEO Buys $70 in Stock, Owns 5M+ Sharesby Mark Eisenberg 25.06.2024CTT Pharmaceutical CEO buys $70 in stock, signaling confidence. Despite recent gains, profitability concerns remain. Investors should monitor closely.